rs7498665 — SH2B1 Thr484Ala

The Leptin Amplifier — SH2B1 and Visceral Fat Risk

SH2B1 (SH2B Adaptor Protein 1) is not a hormone or a receptor — it is the adaptor protein¹¹ adaptor protein
Scaffold proteins that assemble multi-protein signaling complexes at specific cellular locations that turns up the volume on two of the body's most important weight-control signals: leptin and insulin. When SH2B1 works properly, it binds to activated JAK2²² JAK2
Janus Kinase 2 — the intracellular enzyme activated when leptin binds its receptor on hypothalamic neurons, dramatically amplifying its catalytic activity and extending downstream signaling through STAT3³³ STAT3
Signal Transducer and Activator of Transcription 3 — the transcription factor that mediates leptin's appetite-suppressing gene expression program and the PI3-kinase pathway. The rs7498665 variant introduces a single amino acid change that appears to blunt this amplification, particularly in leptin signaling.

The GIANT consortium GWAS⁴⁴ GIANT consortium GWAS
Speliotes et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nature Genetics, 2010 identified the SH2B1 locus as one of 18 new genome-wide significant loci for BMI — notable because it sits alongside FTO, MC4R, POMC, and BDNF as one of the few obesity loci that maps directly to a known hypothalamic regulator of energy balance.

The Mechanism

The Thr484Ala substitution falls in the linker region between SH2B1's two key structural domains: the pleckstrin homology (PH) domain⁵⁵ pleckstrin homology (PH) domain
Binds inactive JAK2; positions SH2B1 at the receptor complex before leptin signaling begins (residues 249-378) and the SH2 domain⁶⁶ SH2 domain
Binds phosphorylated, active JAK2; required for full JAK2 activation and downstream signaling (residues 521-625). Position 484 is thus a structural hinge. The ancestral threonine is a polar, hydroxyl-bearing amino acid; the Ala484 substitution removes this polar group, potentially altering how the two domains orient relative to each other and how efficiently SH2B1 transitions from its inactive to active conformation.

Functional evidence confirms the signaling impact is real but leptin-selective. Experiments in hypothalamic cell lines⁷⁷ Experiments in hypothalamic cell lines
Giuranna et al. The Effect of SH2B1 Variants on Expression of Leptin- and Insulin-Induced Pathways in Murine Hypothalamus. Obesity Facts, 2018 showed that SH2B1 variants collectively altered expression of 34 of 54 analyzed leptin signaling genes, with the 484Ala form among the most impactful. Notably, insulin signaling was unaffected, leading the authors to conclude that "leptin rather than insulin signaling is relevant for the mode of action of SH2B1 variants on energy homeostasis." Mice lacking SH2B1 entirely develop severe hyperleptinemia, obesity, and type 2 diabetes — confirming the gene's essential role.

The Evidence

The Thr484Ala variant has been replicated across multiple independent populations. A Belgian case-control study⁸⁸ Belgian case-control study
Beckers et al. Replication of the SH2B1 rs7498665 association with obesity in a Belgian study population. Obesity Facts, 2011 of 1,045 obese adults and 317 lean controls confirmed the G allele increased obesity risk (OR 1.26, 95% CI 1.04-1.52, p=0.016). Japanese CT imaging data revealed the risk allele was significantly associated with visceral fat area⁹⁹ significantly associated with visceral fat area
Hotta et al. SH2B1 rs7498665 and visceral fat area in Japanese adults. Journal of Human Genetics, 2011 (P=0.00047) but not with overall BMI or subcutaneous fat, suggesting a depot-specific effect — the G allele drives abdominal fat accumulation selectively.

Beyond obesity, a study of 18,014 middle-aged Danes¹⁰¹⁰ 18,014 middle-aged Danes
Sandholt et al. Studies of Metabolic Phenotypic Correlates of 15 Obesity Associated Gene Variants. PLOS ONE, 2011 found the G allele independently increased type 2 diabetes risk even after adjusting for BMI (OR 1.16, p=7.8×10⁻⁴). This BMI-independent diabetes association points to a direct metabolic role for SH2B1 beyond its weight-regulatory function — consistent with SH2B1's role in insulin receptor signaling.

Gene-environment interactions are particularly striking. A 2024 study found that GG homozygotes with elevated fasting glucose¹¹¹¹ GG homozygotes with elevated fasting glucose
Chermon et al. Gene-Environment Interactions Significantly Alter the Obesity Risk of SH2B1 rs7498665 Carriers. Journal of Obesity & Metabolic Syndrome, 2024 (≥90 mg/dL) faced 5.82-fold elevated risk of overweight/obesity — while physical activity (≥150 min/week) reduced GG carriers' obesity risk by 65%.

Practical Actions

Because SH2B1 is the amplifier for leptin's satiety signal, strategies that enhance leptin sensitivity are specifically relevant for G allele carriers. High-protein meals trigger satiety hormones (GLP-1, PYY, CCK) via gut receptors that bypass SH2B1-dependent hypothalamic signaling, providing an alternative brake on appetite. The visceral fat–specific association means that measuring waist circumference, not just weight or BMI, gives a more accurate picture of metabolic risk for this genotype.

The fasting glucose interaction is actionable: keeping fasting glucose below 90 mg/dL substantially modifies risk for GG carriers. This threshold is below the standard prediabetes cutoff (100 mg/dL), making periodic fasting glucose testing an important early warning tool.

Interactions

SH2B1 sits directly upstream of the same leptin-JAK2-STAT3 pathway affected by LEPR (rs1137101). Carrying the G risk allele here while also carrying the G risk allele at LEPR rs1137101 compounds impairment at two consecutive steps in leptin signaling: SH2B1 fails to amplify JAK2, and the receptor itself may respond less efficiently to leptin. The cumulative effect on satiety signaling is greater than either variant alone.

rs7498665 also interacts additively with the major obesity GWAS loci FTO (rs9939609) and MC4R (rs17782313) — each variant contributes an independent BMI increment, and carriers of risk alleles at multiple loci face substantially higher cumulative obesity susceptibility. The IRS1 variant rs2943641 affects the insulin receptor substrate arm of SH2B1 signaling; co-occurrence may compound insulin sensitivity effects.